References
- Mihatsch W, Fewtrell M, Goulet O, Molgaard C, Picaud JC, Senterre T; ESPGHAN/ESPEN/ESPR/CSPEN working group on pediatric parenteral nutrition. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium. Clin Nutr. 2018; 37:2360–5.
- Pereira-da-Silva L, Costa AB, Pereira L, Filipe AF, Virella D, Leal E, et al. Early high calcium and phosphorus intake by parenteral nutrition prevents short-term bone strength decline in preterm infants. J Pediatr Gastroenterol Nutr. 2011; 52:203–9.
- Pereira-da-Silva L, Macedoc I, Rosa ML, Bridgese KM. Calcium and phosphorus intake by parenteral nutrition in preterm infants. In: Rajendram R, Preedy VR, Patel VB, editors. Diet and nutrition in critical care. New York: Springer; 2015, p. 1–16.
- Newton DW, Driscoll DF. Calcium and phosphate compatibility: revisited again. Am J Health Syst Pharm. 2008; 65:73–80.
- Kimura S, Nose O, Seino Y, Harada T, Kanaya S, Yabuuchi H, et al. Effects of alternate and simultaneous administrations of calcium and phosphorus on calcium metabolism in children receiving total parenteral nutrition. J Parenter Enteral Nutr. 1986; 10:513–6.
- MacKay M, Anderson C. Physical compatibility of sodium glycerophosphate and calcium gluconate in pediatric parenteral nutrition solutions. JPEN J Parenter Enteral Nutr. 2015; 39:725–8.
- Mirtallo J, Canada T, Johnson D, Kumpf V, Petersen C, Sacks G; Task Force for the Revision of Safe Practices for Parenteral Nutrition. Safe practices for parenteral nutrition. J Parenter Enteral Nutr. 2004; 28:S39–70.
- Bouchoud L, Fonzo-Christe C, Sadeghipour F, Bonnabry P. Maximizing calcium and phosphate content in neonatal parenteral nutrition solutions using organic calcium and phosphate salts. J Parenter Enteral Nutr. 2010; 34:542–5.
- Anderson C, MacKay M. Physical compatibility of calcium chloride and sodium glycerophosphate in pediatric parenteral nutrition solutions. J Parenter Enteral Nutr. 2016; 40:1166–9.
- Thowladda N, Siritientong T. Compatibility of calcium and sodium glycerophosphate in parenteral nutrition solutions. Thai J Pharm Sci. 2016; 40(Suppl):176–9.
- Ronchera-Oms CL, Jiménez NV, Peidro J. Stability of parenteral nutrition admixtures containing organic phosphate. Clin Nutr. 1995; 14:373–80.
- de Oliveira Ribeiro D, Lobo BW, Volpato NM, da Veiga VF, Cabral LM, de Sousa VP. Influence of the calcium concentration in the presence of organic phosphorus on the physicochemical compatibility and stability of all-in-one admixtures for neonatal use. Nutr J. 2009; 8:51.
- Thowladda N, Siritientong T. Are there maximum compatible concentrations of calcium gluconate and sodium glycerophosphate in infant parenteral nutrition solutions? J Pharm Sci Res. 2018; 10:2074–8.
- Hicks W, Hardy G. Phosphate supplementation for hypophosphatemia and parenteral nutrition. Curr Opin Clin Nutr Metab Care. 2001; 4:227–33.
- Pereira-da-Silva L, Nurmamodo A, Amaral JM, Rosa ML, Almeida MC, Ribeiro ML. Compatibility of calcium and phosphate in four parenteral nutrition solutions for preterm neonates. Am J Health Syst Pharm. 2003; 60:1041–4.
- Prinzivalli M, Ceccarelli S. Sodium d-fructose-1,6-diphosphate vs sodium monohydrogen phosphate in total parenteral nutrition: a comparative in vitro assessment of calcium/phosphate compatibility. J Parenter Enteral Nutr. 1999; 23:326–32.
- Zenoni D, Loiacono S. Experience of compounding total parenteral nutrition admixtures for preterm infants in a hospital pharmacy: evidence of calcium and phosphate compatibility problem. Eur J Hosp Pharm. 2018; 25:38–42.
- Vervloet MG, van Ballegooijen AJ. Prevention and treatment of hyperphosphatemia in chronic kidney disease. Kidney Int. 2018; 93:1060–72.
- Joy J, Silvestri AP, Franke R, Bistrian BR, Nehne J, Newton DW, Driscoll DF. Calcium and phosphate compatibility in low-osmolarity parenteral nutrition admixtures intended for peripheral vein administration. J Parenter Enteral Nutr. 2010; 34:46–54.